Resistance proof, folding-inhibitor drugs

Journal of Chemical Physics

Volumn 118, Issue 10, 2003, Pages 4754-4758

  Broglia, R A ^a,b,c   Tiana, G ^a,b   Berera, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INFN SEZIONE DI MILANO   (Italy)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONS; ENZYME KINETICS; FREE ENERGY; MATHEMATICAL MODELS; MOLECULAR DYNAMICS; NUCLEATION; PROTEINS; STATISTICAL METHODS;

ENZYMATIC ACTIVITY; FOLDING-INHIBITOR DRUGS; MUTATION; NONCONVENTIONAL DRUG DESIGN; RESISTANCE PROOF;

DRUG PRODUCTS;

EID: 0037426186     PISSN: 00219606     EISSN: None     Source Type: Journal    
DOI: 10.1063/1.1545087     Document Type: Article

References (14)

1. E. T. Baldwin et al., Struct. Biol. 2, 192 (1995).
2. P. J. Ala, E. E. Huston, R. M. Klabe et al., Biochemistry 36, 1573 (1997).
3. E. Shakhnovich, Phys. Rev. Lett. 72, 3907 (1994).
4. K. F. Lau and K. Dill, Macromolecules 22, 3986 (1989).
5. G. Tiana, R. A. Broglia, H. E. Roman, E. Vigezzi, and E. I. Shakhnovich, J. Chem. Phys. 108, 757 (1998).
6. S. Miyazawa and R. Jernigan, Macromolecules 18, 534 (1985).
7. G. Tiana and R. A. Broglia, J. Chem. Phys. 114, 2503 (2001).
8. R. A. Boglia and G. Tiana, J. Chem. Phys. 114, 7267 (2001).
9. V. I. Abkevich, A. M. Gutin, and E. I. Shakhnovich, Biochemistry 33, 10026 (1994).
10. R. A. Broglia and G. Tiana, Proteins: Struct., Funct., Genet. 45, 421 (2001).
11. G. Tiana and R. A. Broglia, Proteins: Struct., Funct., Genet. 49, 82 (2002).
12. We indicate with primed numbers the residues belonging to a p-LES, following the numeration of the protein sequence. Thus, 3′-6′ means the p-LES built out of four monomers corresponding to residues 3-6 of the protein.
13. B. Derrida, Phys. Lett. 24B, 2613 (1981).
14. A. R. Fersht, Structure and Mechanism in Protein Science (Freeman, New York, 1999).